Schizophrenia.com
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
News
everhopeful
March 27, 2023, 5:47pm
1
3 Likes
Related topics
Topic
Replies
Views
Activity
Cognition deficits
DX'd - Other
6
220
March 3, 2024
Iclepertin Found Ineffective in Treating Cognitive Impairment Associated With Schizophrenia
News
0
41
November 13, 2025
The price of Iclepertin (for cognitive symptoms)
Medications
2
248
December 6, 2023
Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation
News
3
386
May 24, 2021
Efficacy and Safety of Iclepertin (BI 425809) in Patients With Schizophrenia
News
2
250
February 1, 2024
